ECOG 91140--CDP, DTIC, CARMUSTINE &TAMOXIFEN VS DTIC IN ADVANCED MELANOMA

  • Blum, Ronald (PI)

Project Details

Description

The objectives of this Phase III study are to evaluate the toxicity, anti- tumor effects and overall survival of the combination of cisplatin, dacarbazine, carmustine, and tamoxifen versus dacarbazine alone for advanced melanoma.
StatusFinished
Effective start/end date1/10/9630/09/97

Funding

  • National Center for Research Resources

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.